IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments

Detalles Bibliográficos
Autor principal: Wienands, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182216/
https://www.ncbi.nlm.nih.gov/pubmed/34158836
http://dx.doi.org/10.1177/17562864211022109
_version_ 1783704161744846848
author Wienands, Jürgen
author_facet Wienands, Jürgen
author_sort Wienands, Jürgen
collection PubMed
description
format Online
Article
Text
id pubmed-8182216
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81822162021-06-21 IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments Wienands, Jürgen Ther Adv Neurol Disord Editorial SAGE Publications 2021-06-03 /pmc/articles/PMC8182216/ /pubmed/34158836 http://dx.doi.org/10.1177/17562864211022109 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Editorial
Wienands, Jürgen
IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title_full IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title_fullStr IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title_full_unstemmed IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title_short IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
title_sort igg antibody titers to sars-cov-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182216/
https://www.ncbi.nlm.nih.gov/pubmed/34158836
http://dx.doi.org/10.1177/17562864211022109
work_keys_str_mv AT wienandsjurgen iggantibodytiterstosarscov2revealadistinctefficacyofmultiplesclerosismodifyingtherapiestocurtaillymphocytecompartments

Ejemplares similares